Women employed at Novo Nordisk A/S are now paid more on average than the men working at the maker of blockbuster drugs Wegovy ...

Novo Nordisk was Europe's most valuable company, with a big lead on obesity drugs with its runaway hits Ozempic and Wegovy.

Novo Nordisk warned the US government not to impose pharma-specific tariffs, but instead to tax illegal importers of ...

Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...

The nonprofit foundation, which awards grants in health, sustainability and the life science ecosystem, holds 77% of the votes and 28% of the shares in pharma giant Novo Nordisk through Novo Holdings.

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing medicine, Zepbound, the Danish pharmaceutical behemoth Novo Nordisk A/S ...

Novo Nordisk ... versions of Novo Nordisk's Wegovy GLP-1 drug. This development comes as the compounding pharmacy industry seeks a way to coexist with the big pharmaceutical companies that ...

Outside of pipeline issues, Novo Nordisk and the rest of the pharmaceutical industry are grappling with the Trump administration's ambitions to lower drug prices and bring manufacturing to the U.S ...